Skip to main content
CivicGate

S 921
Passed Senate Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Tyler’s Law

Introduced Mar 10, 2025

Latest action (Mar 24, 2026) Held at the desk.

Referred to
Health, Education, Labor, and Pensions Committee
Policy area
Health
Issues
Healthcare
Legislative subjects (6)
Drug, alcohol, tobacco useEmergency medical services and trauma careGovernment information and archivesGovernment studies and investigationsHospital careMedical tests and diagnostic methods

Summary
  • Directs the Secretary of Health and Human Services to conduct a study on fentanyl and fentanyl-related substance testing in hospital emergency departments for patients experiencing overdose.
  • The study must be completed within three years and must examine how frequently testing occurs, scenarios where it is not administered, costs, benefits and risks, staff training needs, and impact on patient experience including privacy protections.
  • The study must also examine barriers to implementing fentanyl testing in emergency departments and provide recommendations to address those barriers.
  • Within nine months after the study is complete, the Secretary must issue guidance on whether emergency departments should implement fentanyl testing as a routine procedure for overdose patients.
  • The guidance must address how hospitals can inform healthcare staff about what substances are tested, how testing may affect future overdose risk and health outcomes, and what federal resources are available to assist with implementation.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)
13 cosponsors

Actions (10)
  1. Mar 24, 2026 Held at the desk. · house
  2. Mar 24, 2026 Received in the House. · house
  3. Mar 24, 2026 Message on Senate action sent to the House. · senate
  4. Mar 23, 2026 Passed Senate with an amendment by Unanimous Consent. (consideration: CR S1559-1560; text: CR S1559-1560) · senate
  5. Mar 23, 2026 Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
  6. Jan 28, 2026 Placed on Senate Legislative Calendar under General Orders. Calendar No. 307. · senate
  7. Jan 28, 2026 Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report. · senate
  8. Jan 15, 2026 Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably. · senate
  9. Mar 10, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · senate
  10. Mar 10, 2025 Introduced in Senate

More bills on these subjects (8)

Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).

  • HR 2004 — Tyler’s Law (shares 6 subjects)
  • HR 1654 — CUTS Act (shares 5 subjects)
  • HR 136 — Veteran Overmedication and Suicide Prevention Act of 2025 (shares 5 subjects)
  • HR 191 — Inflation Reduction Act of 2025 (shares 5 subjects)
  • HR 8870 — BUILD America 250 Act (shares 4 subjects)
  • HR 7148 — Consolidated Appropriations Act, 2026 (shares 4 subjects)
  • HR 7006 — Financial Services and General Government and National Security, Department of State, and Related Programs Appropriations Act, 2026 (shares 4 subjects)
  • HR 5371 — Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (shares 4 subjects)

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

  • HR 2004 — Tyler’s Law · Passed House Sep 16, 2026 · Cong. 119 86%
  • S 690 — Overdose RADAR Act · Introduced Feb 24, 2025 · Cong. 119 64%
  • HR 9676 — Examining Opioid Treatment Infrastructure Act of 2026 · Introduced Jul 14, 2026 · Cong. 119 64%
  • S 165 — Stopping Overdoses of Fentanyl Analogues Act · Introduced Jan 21, 2025 · Cong. 119 64%
  • HR 920 — Federal Initiative to Guarantee Health by Targeting Fentanyl Act · Introduced Feb 4, 2025 · Cong. 119 63%
  • HR 8005 — Stop Pills That Kill Act · Passed House Sep 16, 2026 · Cong. 119 63%

Text versions (3)
  • Engrossed in Senate · Mar 23, 2026
  • Reported to Senate · Jan 28, 2026
  • Introduced in Senate · Mar 10, 2025

Full text

AN ACT

To direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as “Tyler’s Law”.

SEC. 2. TESTING FOR FENTANYL IN HOSPITAL EMERGENCY DEPARTMENTS.

(a) Study.—Not later than 3 years after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Assistant Secretary for Mental Health and Substance Use and in coordination with other Federal departments, agencies, or stakeholders, as appropriate, shall complete a study to determine—

(1) how frequently hospital emergency departments test for fentanyl or fentanyl-related substances when a patient is experiencing an overdose, and test for other controlled substances related to such an overdose;

(2) scenarios in which hospital emergency departments do not administer tests for fentanyl or fentanyl-related substances when a patient is experiencing an overdose, or for other controlled substances related to such an overdose;

(3) the costs associated with such testing for fentanyl or fentanyl-related substances;

(4) the potential benefits and risks for patients receiving such testing for fentanyl or fentanyl-related substances;

(5) potential staff training needs to support testing for fentanyl or fentanyl-related substances;

(6) how testing for fentanyl or fentanyl-related substances in hospital emergency departments may impact the experience of the patient, including—

(A) protections for the privacy and security of the patient’s protected health information (as defined in section 160.103 of title 45, Code of Federal Regulations (or any successor regulations)) under part 160 of title 45, Code of Federal Regulations, and subparts C and E of part 164 of title 45, Code of Federal Regulations (or any successor regulations); and

(B) the patient-health care professional relationship; and

(7) barriers that hospital emergency departments may encounter when trying to implement testing for fentanyl or fentanyl-related substances and recommendations on how best to address those barriers.

(b) Guidance.—Not later than 9 months after completion of the study under subsection (a), based on the results of such study, the Secretary of Health and Human Services, acting through the Assistant Secretary for Mental Health and Substance Use and in coordination with other Federal departments, agencies, or stakeholders, as appropriate, shall issue guidance on the following:

(1) Whether hospital emergency departments should implement testing for fentanyl or fentanyl-related substances as a routine procedure for patients experiencing an overdose.

(2) How hospitals can ensure that health care professionals in their hospital emergency departments are aware of which substances are being tested for in their routinely-administered drug tests, regardless of whether those tests screen for fentanyl or fentanyl-related substances.

(3) How the administration of testing for fentanyl or fentanyl-related substances in hospital emergency departments may affect the future risk of overdose and health outcomes.

(4) Available Federal resources that can assist hospital emergency departments in implementing testing for fentanyl or fentanyl-related substances.

(c) Definitions.—In this section, the term “hospital emergency department” means an emergency department of a hospital or an independent freestanding emergency department (as such terms are defined in section 2799A-1(a)(3) of the Public Health Service Act (42 U.S.C. 300gg-111(a)(3))).

Passed the Senate March 23, 2026.

Attest:

Secretary. 119th CONGRESS

2d Session

S. 921

AN ACT

To direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, and for other purposes.

Comments

Comments

Loading comments…